Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

In vivo agents comprising cationic drugs, peptides and metal chelators with acidic saccharides and glycosaminoglycans, giving improved site-selective localization, uptake mechanism, sensitivity and kinetic-spatial profiles, including tumor sites

US Patent 6106866 · Granted Aug 22, 2000

Estimated economic value: $889,000

Assignee

Inventors

View full patent text on Google Patents →